44 results on '"Nordstrom, Dan"'
Search Results
2. Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
3. Evidence-Based Practices in Mentoring Students with Disabilities: Four Case Studies
4. Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study
5. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
6. Safety outcomes in patients with rheumatoid arthritis treated with abatacept:results from a multinational surveillance study across seven European registries
7. Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration
8. Additional file 1 of Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
9. Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
10. Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial
11. State of the science on the Cloud, accessibility, and the future
12. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics:a Nordic population-based cohort study
13. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study
14. Does Drug Effectiveness of 2nd and 3rd TNF Inhibitors in Patients with Psoriatic Arthritis Depend on the Reason for Withdrawal from the Previous Treatment? - Results from the EuroSpA Research Collaboration
15. Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study)
16. TREATMENT RESPONSE AND DRUG RETENTION RATES IN 23,956 BIOLOGIC-NAIVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING TNFI TREATMENT - ROUTINE CARE DATA FROM 12 REGISTRIES IN THE EUROSPA COLLABORATION
17. DRUG RETENTION AND REMISSION RATES IN 14,261 BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS STARTING TNF INHIBITOR TREATMENT IN ROUTINE CARE - RESULTS FROM 12 REGISTRIES IN THE EUROSPA RESEARCH COLLABORATION
18. Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial
19. Drug Retention and Response Rates of TNFi Treatment in 21,470 Patients with Axial Spondyloarthritis Treated in Clinical Practice-Pooled Data from the Eurospa Research Network Collaboration
20. Similar Pleural Fluid Findings in Pleuropulmonary Tularemia and Tuberculous Pleurisy*
21. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
22. Loin Pain And Haematuria Syndrome: Possible Association With Intrarenal Arterial Spasms
23. Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort
24. Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis
25. Toll-like receptors in human chondrocytes and osteoarthritic cartilage
26. Reactive arthritis, diagnosis and treatment
27. Distribution of adhesion receptors in recurrent oral ulcers
28. Immunologic studies of nonunited fractures
29. Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study.
30. Recruitment of Students with Disabilities: Exploration of Science, Technology, Engineering, and Mathematics.
31. Effect of Joint Mobilization on Serum Hyaluronate
32. Rituximab Done! What's Next in RA?
33. Efficacy of Different Doses of Rituximab for the Treatment of Rheumatoid Arthritis: Data From the CERERRA Collaboration
34. Characterization of Long-Term Responders to First Treatment Course of Rituximab (RTX)-Results From the CERERRA Collaboration
35. Fixed Versus On-Flare Retreatment With Rituximab In RA-Results From The Cererra Collaboration
36. Early Versus Delayed Retreatment with Rituximab (RTX) in Relation to Long Term Clinical Response-Data From the CERERRA Collaboration
37. Smoking and Response to Rituximab in Anti-CCP Positive and Negative Rheumatoid Arthritis - Results from an International European Collaboration
38. Seven-hundred and fifty patients treated with rituximab for RA in European registries: Baseline data analysis from the Collaborative European Registries for Rituximab in RA (CERERRA)
39. SEROPOSITIVITY AND RESPONSE TO RTX: DATA FROM THE CERERRA COLLABORATION
40. High Baseline Patient's Compared with Evaluator's Global Assessment Is Associated with Lower Retention and Remission Rates of First TNF Inhibitor in Psoriatic Arthritis Patients - Data from the EuroSpA Research Collaboration Network
41. Effectiveness Of Tocilizumab In Monotherapy and In Combination With Different Synthetic Dmards: A Registry-Based Comparison Study
42. PolyTrac - A Unique Approach to Engineering Problems
43. Occurrence of different ensuing triggering infections preceding reactive arthritis infections preceding reactive arthritis: a follow up study .
44. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.